About UND Life Sciences

UND Life Sciences is a privately held biotech company founded in 2007 with a focus on developing lipid-based therapeutic approaches for difficult-to-treat diseases. Our research centers on understanding how specific fatty acids may affect disease processes and developing practical approaches to deliver these compounds where they're needed. We are committed to rigorous scientific development and appropriate regulatory processes as we advance our programs. UND Life Sciences focuses on the role of essential fatty acids (EFAs) and their metabolites in the pathobiology of diabetes mellitus (DM), diabetic retinopathy (DR), glioblastoma multiforme (glioma), sepsis, lupus and antibiotic resistance of bacteria and other organisms.

About the Inventor and CEO: The original research (both lab based and human studies) performed by Dr. Undurti N Das, MD, FAMS, FRSC for the past 35 years forms the basis of the portfolio of UND Life Sciences. His work formed the basis of 5 issued USA and 3 issued Indian patents. Dr. Das is also the author of more than 600 research publications and authored 4 books and co-edited three books on Autism. He contributed chapters to several books. He has more than 550 publications. 17 students got their PhD under his guidance and he mentored many MD students.